Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4-c)pyrazol-5(4h)-yl)tetrahydro-2h-pyran-3-amine
2. Mk-3102
1. 1226781-44-7
2. Mk-3102
3. Mk3102
4. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2h,4h,6h)-yl)tetrahydro-2h-pyran-3-amine
5. Cvp59q4je1
6. Unii-cvp59q4je1
7. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4h)-yl)tetrahydro-2h-pyran-3-amine
8. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4h)-yl]tetrahydro-2h-pyran-3-amine
9. 2h-pyran-3-amine, 2-(2,5-difluorophenyl)-5-(2,6-dihydro-2-(methylsulfonyl)pyrrolo(3,4-c)pyrazol-5(4h)-yl)tetrahydro-,(2r,3s,5r)-
10. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine
11. Omarigliptin [usan]
12. Omarigliptin [usan:inn]
13. Omarigliptin [mi]
14. Omarigliptin [inn]
15. Omarigliptin [jan]
16. Omarigliptin (mk-3102)
17. Omarigliptin [who-dd]
18. Schembl827590
19. Ambz0104
20. Gtpl8402
21. Omarigliptin (jan/usan/inn)
22. Chembl2105762
23. Dtxsid70153678
24. Ex-a395
25. Chebi:134735
26. Bdbm50003020
27. Mfcd22573261
28. Nsc802900
29. S8565
30. Zinc84758480
31. Akos025289528
32. Am85511
33. Ccg-268634
34. Cs-3948
35. Db11992
36. Ds-7574
37. Nsc-802900
38. Pb39113
39. Ncgc00480770-01
40. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methanesulfonyl)-2,6-dihydropyrrolo(3,4- C)pyrazol-5(4h)-yl)oxan-3-amine
41. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4- C)pyrazol-5(4h)-yl)tetrahydro-2h-pyran-3-amine
42. 2h-pyran-3-amine, 2-(2,5-difluorophenyl)-5-(2,6-dihydro-2-(methylsulfonyl)pyrrolo(3,4- C)pyrazol-5(4h)-yl)tetrahydro-, (2r,3s,5r)-
43. Ac-28992
44. Hy-15981
45. D10317
46. L10002
47. J-690074
48. Q21098979
49. (2r,3s,5r)-2-(2,5-difluorophenyl)-5[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4h)-yl]tetrahydro-2h-pyran-3-amine
50. 2h-pyran-3-amine, 2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4h)-yl]tetrahydro-, (2r,3s,5r)-
| Molecular Weight | 398.4 g/mol |
|---|---|
| Molecular Formula | C17H20F2N4O3S |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 398.12241801 g/mol |
| Monoisotopic Mass | 398.12241801 g/mol |
| Topological Polar Surface Area | 98.8 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 649 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
Market Place
ABOUT THIS PAGE
A Omarigliptin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Omarigliptin, including repackagers and relabelers. The FDA regulates Omarigliptin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Omarigliptin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Omarigliptin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Omarigliptin supplier is an individual or a company that provides Omarigliptin active pharmaceutical ingredient (API) or Omarigliptin finished formulations upon request. The Omarigliptin suppliers may include Omarigliptin API manufacturers, exporters, distributors and traders.
click here to find a list of Omarigliptin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Omarigliptin DMF (Drug Master File) is a document detailing the whole manufacturing process of Omarigliptin active pharmaceutical ingredient (API) in detail. Different forms of Omarigliptin DMFs exist exist since differing nations have different regulations, such as Omarigliptin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Omarigliptin DMF submitted to regulatory agencies in the US is known as a USDMF. Omarigliptin USDMF includes data on Omarigliptin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Omarigliptin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Omarigliptin suppliers with USDMF on PharmaCompass.
Omarigliptin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Omarigliptin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Omarigliptin GMP manufacturer or Omarigliptin GMP API supplier for your needs.
A Omarigliptin CoA (Certificate of Analysis) is a formal document that attests to Omarigliptin's compliance with Omarigliptin specifications and serves as a tool for batch-level quality control.
Omarigliptin CoA mostly includes findings from lab analyses of a specific batch. For each Omarigliptin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Omarigliptin may be tested according to a variety of international standards, such as European Pharmacopoeia (Omarigliptin EP), Omarigliptin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Omarigliptin USP).
LOOKING FOR A SUPPLIER?
